Physician
Endocrinology
Dr. Ken Chiu, MD
|
|
Give Review
Doctor Ken Chiu, MD practices Endocrinology. He went to Taipei Medical College. He received 1 awards: "Fellow (FACE)". Ken Chiu is also published. He has 84 publications published. The lastest publication: "Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.' Chiu accepts Medicare payments and is registered with Medicare.gov.
Publications
- Proposed Guidelines for Future Vitamin D Studies.
- Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
- Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention.
- Clinical implication of fasting and post-challenged plasma glucose in diagnosis of Diabetes mellitus.
- Clinical implication of vitamin D threshold.
- Calcium supplements and fracture prevention.
- Insulin resistance is not necessarily an essential element of metabolic Syndrome.
- Lifestyle intervention improves heart rate recovery from exercise in adults with type 2 Diabetes: results from the Look AHEAD study.
- Adiponectin and the mediation of HDL cholesterol change With improved lifestyle: The Look AHEAD Study.
- Association of hyperglycemia With prolonged hospital stay but no effect on engraftment after autologous hematopoietic stem cell transplantation.
- Plasma 25-hydroxyvitamin D levels are favorably associated With beta-cell function.
- Sellar plasmacytomas: a concise review.
- One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 Diabetes in the Look AHEAD study.
- Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 Diabetes: results from the Look AHEAD randomized trial.
- Factors influencing enrollment of African Americans in the Look AHEAD trial.
- Neighborhood socioeconomic status, depression, and health status in the Look AHEAD (Action for Health in Diabetes) study.
- Interaction of BMI With vitamin D and insulin sensitivity.
- Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 Diabetes: results from the Look AHEAD trial.
- Intensive lifestyle intervention improves physical function among obese adults With knee pain: findings from the Look AHEAD trial.
- Neighborhood and weight-related health behaviors in the Look AHEAD (Action for Health in Diabetes) study.
- Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenoTypes in Taiwanese adolescents and Caucasian young adults.
- Describing patterns of weight changes using principal components analysis: results from the Action for Health in Diabetes (Look AHEAD) research group.
- Action for Health in Diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake.
- One-year weight losses in the Look AHEAD study: factors associated With success.
- Impact of a weight management program on health-related quality of life in overweight adults with type 2 Diabetes.
- Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 Diabetes in the Chinese population.
- Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects.
- Impact of apolipoprotein A5 polymorphisms on insulin sensitivity and beta-cell function.
- Comparison of the relationship of age and beta cell function in three ethnic groups.
- Association of leptin receptor polymorphism With insulin resistance.
- Hypovitaminosis D is associated With insulin resistance and beta cell dysfunction.
- Association of paraoxonase 1 polymorphism With beta-cell function: a case of molecular heterosis.
- New insulin sensitivity adjusted beta cell indices: validation according to a genetic study.
- The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians.
- Comparison of the impact of the I27L polymorphism of the hepatocyte nuclear factor-1alpha on estimated and measured beta cell indices.
- Transcription factor 1 and beta-cell function in glucose-tolerant subjects.
- Hepatic glucokinase promoter polymorphism is associated With hepatic insulin resistance in Asian Indians.
- The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated With insulin resistance in glucose tolerant Caucasians.
- The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 Diabetes in Taiwanese people.
- Relative contribution of insulin sensitivity and beta-cell function to plasma glucose and insulin concentrations during the oral glucose tolerance test.
- Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 Diabetes.
- Fatty acid binding protein 2 and insulin resistance.
- Comparison of measured and estimated indices of insulin sensitivity and beta cell function: impact of ethnicity on insulin sensitivity and beta cell function in glucos...
- Insulin sensitivity differs among ethnic groups With a compensatory response in beta-cell function.
- Beta cell function declines With age in glucose tolerant Caucasians.
- Insulin sensitivity is inversely correlated with plasma intact paraThyroid hormone level.
- Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide.
- Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity.
- Vitamin D receptor gene polymorphisms influence susceptibility to type 1 Diabetes mellitus in the Taiwanese population.
- The I27L amino acid polymorphism of hepatic nuclear factor-1alpha is associated With insulin resistance.
- Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin.
- Familial hyperinsulinism With apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.
- Nucleotide(-258) G-to-A transition variant of the liver glucokinase gene is associated With essential hypertension.
- Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent Diabetes mellitus, and coronary heart ...
- Genetics of NIDDM in France: studies With 19 candidate genes in affected sib pairs.
- The insertion allele at the angiotensin I-converting enzyme gene locus is associated With insulin resistance.
- The GENNID Study. A resource for mapping the genes that cause NIDDM.
- Mitochondrial gene mutations in familial non-insulin-dependent Diabetes mellitus in Taiwan.
- CA-repeated microsatellite polymorphism of the glucokinase gene and its association with non-insulin-dependent Diabetes mellitus in Taiwanese.
- Exclusion of adenosine deaminase gene locus on chromosome 20q12-13.1 in familial NIDDM in Taiwanese patients.
- Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent Diabetes mellitus.
- Identification of trinucleotide repeat-containing genes in human pancreatic islets.
- Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM.
- Recombinant mapping of the familial hyperinsulinism gene to an 0.8 cM region on chromosome 11p15.1 and demonstration of a founder effect in Ashkenazi Jews.
- Dinucleotide repeat polymorphism at the human CCKBR locus.
- Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene.
- Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.
- A mutation in the Glut2 glucose transporter gene of a Diabetic patient abolishes transport activity.
- Glucokinase gene in gestational Diabetes mellitus: population association study and molecular scanning.
- Two microsatellite repeat polymorphisms flanking opposite ends of the human glucokinase gene: use in haploType analysis of Welsh Caucasians with Type 2 (non-insulin-de...
- Glucokinase gene variants in the common form of NIDDM.
- Non-sense mutation of glucokinase gene.
- Glucokinase and NIDDM. A candidate gene that paid off.
- Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism.
- A genetic marker at the glucokinase gene locus for type 2 (non-insulin-dependent) Diabetes mellitus in Mauritian Creoles.
- Glucokinase gene is genetic marker for NIDDM in American blacks.
- Linkage of type 2 Diabetes to the glucokinase gene.
- Covalent linkage of phosphoinositides to myelin basic protein: in vitro incorporation of [32P] phosphoinositides to myelin basic protein.
- Colvalent linkage of phosphoLipid to myelin basic protein: identification of phosphatidylinositol bisphosphate as the attached phosphoLipid.
- Covalent linkage of phosphoLipid to myelin basic protein: identification of serine-54 as the site of attachment.
- Covalent linkage of phosphoinositides to myelin basic protein: in vivo occurrence and in vitro studies With experimental allergic encephalomyelitis.
- The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination.
- The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance.
Schools
Taipei Medical University
Mackay Memorial Hospital
St Luke Hospital and St Louis Regional Medical Center
Washington University School Of Medicine
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Cushing's Syndrome
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Fellow (FACE)
Education
-
Washington University - Barnes-Jewish Hospital -
Taipei Medical College
Hospital
-
City of Hope's Helford Clinical Research Hospital
Drug Facts
| NPI NUMBER | 1639126691 | |
| NPPES Provider LastName | CHIU | |
| NPPES Provider FirstName | KEN | |
| NPPES Provider ZIPCode | 91010 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1779.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639126691 |
| Last Name Of The Provider | CHIU |
| First Name Of The Provider | KEN |
| View All |
Similar Doctors
|
Dr. Azarmindokht Khosravi, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Wei Feng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akshay B. Jain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raynald A. Samoa, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Fouad Kandeel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arsalan Geula, MD
This Doctor is OpenDoctor Recommended.
|